Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000697709 | SCV000826335 | pathogenic | Charcot-Marie-Tooth disease, type 2 | 2019-12-03 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with threonine at codon 213 of the MFN2 protein (p.Ile213Thr). The isoleucine residue is highly conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of autosomal dominant Charcot-Marie-Tooth disease (PMID: 16043786, Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 575481). This variant has been reported to affect MFN2 protein function (PMID: 198122151). For these reasons, this variant has been classified as Pathogenic. |
Inherited Neuropathy Consortium | RCV000789396 | SCV000928751 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |